Premier Fund Managers Ltd boosted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 13.4% during the 4th quarter, HoldingsChannel reports. The firm owned 12,468 shares of the company’s stock after purchasing an additional 1,474 shares during the period. Premier Fund Managers Ltd’s holdings in Ryan Specialty were worth $794,000 as of its most recent filing with the SEC.
Other institutional investors have also added to or reduced their stakes in the company. Rakuten Securities Inc. bought a new stake in shares of Ryan Specialty during the 4th quarter valued at $27,000. Principal Securities Inc. lifted its holdings in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after acquiring an additional 415 shares during the last quarter. Quarry LP boosted its position in shares of Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after buying an additional 422 shares during the period. Harvest Fund Management Co. Ltd purchased a new stake in Ryan Specialty in the fourth quarter worth $54,000. Finally, Loomis Sayles & Co. L P increased its position in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after acquiring an additional 286 shares during the period. 84.82% of the stock is currently owned by institutional investors.
Insider Activity
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 10,485 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the sale, the director now directly owns 11,109 shares in the company, valued at approximately $723,418.08. This represents a 48.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 241,360 shares of company stock worth $16,006,428 over the last 90 days. 11.10% of the stock is currently owned by company insiders.
Ryan Specialty Trading Up 1.8 %
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. On average, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date was Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio (DPR) is currently 69.57%.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. Royal Bank of Canada cut their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. UBS Group boosted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Finally, Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $75.27.
Get Our Latest Research Report on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- What is a penny stock? A comprehensive guide
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How to Use the MarketBeat Dividend Calculator
- Top 3 Beverage Stocks Pouring Out Profits
- 3 Tickers Leading a Meme Stock Revival
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.